Infectious disease
Yesterday it was reported that the two companies were working to make more of their vaccine than the 1.3 billion it promised to manufacture in 2021.
It has been thought that llamas may hold the key to developing an effective therapeutic against COVID-19, as well as the flu. This morning, scientists from the National Institutes of Health made additional headway in llama research, isolating promising antibodies from the South American animal.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for December 29, 2020.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
At the moment, eight clinical trials are currently being carried out to determine if the link between melatonin and the novel coronavirus is legitimate.
In a December 8, 2020 meeting with U.K. scientists and public health experts, it was announced that there was a growing new strain of the SARS-CoV-2 virus that causes COVID-19.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for December 22, 2020.
A new and more easily transmissible strain of COVID-19, dubbed VUI-202012/01, has now been reported in at least six different countries and global territories since it first appeared in the U.K. a few weeks ago.
The company and Operation Warp Speed began distribution of the vaccine through McKesson, along with United Parcel Services and FedEx, over the weekend. The first vaccinations are expected today.
Many companies appear to be getting their clinical trial news updated ahead of the holidays. Here’s a look.
PRESS RELEASES